NCT02469532View on ClinicalTrials.gov

DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes

CompletedOBSERVATIONAL
Enrollment

31

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

January 31, 2018

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

Balloon Angioplasty

Device: Balloon Angioplasty Selection is driven by preference of the operator

DEVICE

Atherectomy System

Device: Orbital or Directional or Laser Atherectomy Systems Atherectomy selection is driven by preference of the operator

Trial Locations (6)

7111

Endovascular Technologies (Willis Knighton Medical Center), Bossier City

39401

Hattiesburg Clinic, Hattiesburg

72211

Arkansas Heart Hospital, Little Rock

75801

Palestine Regional Medical Center, Palestine

78130

Mission Research Institute, New Braunfels

Unknown

Rex Hospital, Raleigh

Sponsors
All Listed Sponsors
lead

Mercator MedSystems, Inc.

INDUSTRY

NCT02469532 - DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes | Biotech Hunter | Biotech Hunter